CHA
OGN icon

Carmichael Hill & Associates’s Organon & Co OGN Stock Holding History

Carmichael Hill & Associates’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$4.78K Hold
250
– – ﹤0.01% 663
2024
Q2 		$5.17K Hold
250
– – ﹤0.01% 641
2024
Q1 		$4.7K Buy
250
+200
+400% +$3.43K ﹤0.01% 639
2023
Q4 		$721 Sell
50
-220
-81% -$2.99K ﹤0.01% 752
2023
Q3 		$4.69K Hold
270
– – ﹤0.01% 645
2023
Q2 		$5.62K Sell
270
-109
-29% -$2.37K ﹤0.01% 632
2023
Q1 		$8.91K Hold
379
– – ﹤0.01% 569
2022
Q4 		$10.6K Sell
379
-70
-16% -$1.79K 0.01% 544
2022
Q3 		$11K Buy
449
+50
+13% +$1.51K 0.01% 549
2022
Q2 		$13K Sell
399
-108
-21% -$3.78K 0.01% 519
2022
Q1 		$18K Sell
507
-90
-15% -$3.08K 0.01% 515
2021
Q4 		$18K Buy
597
+1
+0.2% +$33 0.01% 534
2021
Q3 		$20K Sell
596
-130
-18% -$4.16K 0.01% 516
2021
Q2 		$22K Buy
+726
New +$23.9K 0.01% 500

Other funds holding OGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return
SSM
Sound Shore Management Greenwich, Connecticut $2.98B AUM 22.67% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
DRZID
DePrince Race & Zollo Inc (DRZ) Winter Park, Florida $5.29B AUM 20.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Carmichael Hill & Associates's OGN Position: Q3 2024 in Review

Carmichael Hill & Associates held its Organon & Co (OGN) position steady in Q3 2024 at 250 shares worth $4.78K. The position accounts for ﹤0.01% of the portfolio, ranked #663.

Carmichael Hill & Associates first reported a position in OGN in Q2 2021 and has held it in 14 quarters since. The position peaked at $22K in Q2 2021. 723 funds tracked by Wall St. Rank hold OGN as of Q3 2024.

  • Carmichael Hill & Associates held 250 shares of Organon & Co worth $4.78K as of Q3 2024.
  • Carmichael Hill & Associates left its Organon & Co share count unchanged in Q3 2024.
  • Organon & Co made up ﹤0.01% of Carmichael Hill & Associates's portfolio in Q3 2024, its #663 holding.
  • Carmichael Hill & Associates first reported a position in Organon & Co in Q2 2021 and has held it in 14 quarters since.
  • Carmichael Hill & Associates's Organon & Co position peaked at $22K in Q2 2021.
  • 723 funds tracked by Wall St. Rank held Organon & Co as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.